Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Complement System

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...

Bacterial Meningitis

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...

Bacterial Meningitis II: Pathophysiology

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...

Bacterial Meningitis I: Introduction

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...

Selectins

Selectins

Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain, which...

Formation of Lipopolysaccharides

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Long-term immune and epigenetic dysregulation following COVID-19.

Clinical immunology (Orlando, Fla.)·2025

Same author

Precision Immunotherapy to Improve Sepsis Outcomes: The ImmunoSep Randomized Clinical Trial.

JAMA·2025

Same author

Evolving our understanding of trained immunity.

eLife·2025

Same author

Genetic determinants of the complement and coagulation pathways in invasive meningococcal disease.

The Journal of allergy and clinical immunology·2025

Same author

Novel loci and biomedical consequences of iron homoeostasis variation.

Communications biology·2024

Same author

Explorative study on the value of hepcidin in predicting iron non-responsiveness in paediatric inflammatory bowel disease.

Pediatric research·2024

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature

Published on: April 1, 2014

Mannose-binding lectin is a critical factor in systemic complement activation during meningococcal septic shock.

Tom Sprong¹, Tom Eirik Mollnes, Chris Neeleman

¹Department of General Internal Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands. t.sprong@aig.umcn.nl

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America

|October 2, 2009

Summary

Meningococcal septic shock severity is linked to complement activation. Mannose-binding lectin (MBL) deficiency reduces complement activation, suggesting MBL is critical in severe meningococcal disease.

More Related Videos

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Related Experiment Videos

Last Updated: Jun 19, 2026

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature

Published on: April 1, 2014

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Area of Science:

Immunology
Infectious Diseases
Critical Care Medicine

Background:

Systemic complement activation correlates with severe meningococcal disease and poor outcomes.
The precise mechanism driving complement activation in meningococcal disease remains unclear.
Understanding complement activation is vital for developing targeted therapies.

Purpose of the Study:

To investigate the role of mannose-binding lectin (MBL) in complement activation during meningococcal disease.
To assess the impact of MBL deficiency on disease severity and complement pathway activation.

Main Methods:

Studied complement activation in 22 patients with meningococcal disease, including those with septic shock.
Compared complement component levels (C3bc, C4bc, C3bBbP, TCC) in MBL-deficient versus MBL-sufficient patients.
Utilized a meningococcal sepsis model to evaluate the effect of lectin pathway deficiency.

Main Results:

MBL-deficient patients exhibited lower disease severity and milder disseminated intravascular coagulation (DIC).
Significantly reduced levels of C3bc and terminal complement complex were observed in MBL-deficient patients.
Systemic complement activation strongly correlated with disease severity and DIC parameters.

Conclusions:

Mannose-binding lectin (MBL) plays a critical role in systemic complement activation during meningococcal septic shock.
Deficiency in MBL leads to reduced complement activation and milder disease manifestations.
This highlights MBL as a key factor in the pathogenesis of severe meningococcal disease.